# Final Factual Correction Audit Report

**Audit Goal**: Fact-check all analytical conclusions, numerical statements, date boundaries, and reproducibility instructions against the validated Golden Dataset (`data/golden/`).  
**Audit Execution Date**: 2026-08-22  

---

## 1. Factual Corrections Matrix

| Issue ID | Description / Area | Original Statement | Actual Verified Data Value | Correction Made | Files Updated |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **ISSUE-01** | **Analysis Time Horizon** | "12-Month Collections Dataset" | Dataset contains 7 complete months (Jan–Jul 2026) + 8 days of partial August 2026 data. | Standardized term to "8-Month Evaluation Window (7 Complete Months: Jan–Jul 2026 + Partial August 2026 Data)". | `README.md`, `reports/*`, `dashboard/app.py`, `index.html` |
| **ISSUE-02** | **11% Claim MoM Transitions** | "Growth was negative in 4 out of 6 full months" | Clean Recovery Rate dropped in 6 out of 6 full-month transitions (Jan to Jul). Gross recovery had a single March bump (+12.23%). | Clarified: "Clean Recovery Rate fell in 6 out of 6 complete monthly transitions. Reported 11% claim was based on a single March gross surge." | `reports/11_percent_claim.md`, `reports/executive_memo.md`, `README.md` |
| **ISSUE-03** | **DiD Counterfactual Terminology** | Mixed phrasing between "net loss" and "net lift" | Treatment group decay (-₹2,761/acc) was smaller than Control group decay (-₹6,254/acc), yielding a positive DiD estimator of +₹3,492.80/acc (+₹38.52M net volume lift). | Standardized to "Strategy v3 digital automation mitigated yield decay by +₹3,492.80/account (+₹38.52M volume lift over counterfactual v2 baseline)." | `reports/counterfactual.md`, `reports/investment_case.md`, `reports/executive_memo.md` |
| **ISSUE-04** | **Automated Test Count** | "6 Automated Quality Tests" | `tests/test_data_quality.py` contains exactly 5 test functions. | Updated count to "5 Automated Quality Tests (100% PASS Rate)". | `README.md`, `docs/architecture.md`, `reports/golden_dataset_report.md` |
| **ISSUE-05** | **PyTest Script Portability** | Hardcoded `c:\Users\HP\...` paths in PyTest | `test_data_quality.py` failed if run from different working directory or machine. | Refactored PyTest script using relative `Path(__file__).resolve().parent.parent` pathing. | `tests/test_data_quality.py`, `submission/tests/test_data_quality.py` |
| **ISSUE-06** | **Reproducibility Instructions** | Referencing `scratch/` one-off files in README | README instructions pointed to transient scratch files. | Created formal `scripts/` directory with `scripts/build_pipeline.py` and updated reproducibility guides. | `README.md`, `docs/reproducibility.md`, `submission/README.md` |

---

## 2. Critical Issues Fixed
1. Corrected date range references from "12-month dataset" to **"8-Month Evaluation Window (7 Complete Months + Partial Aug 2026)"**.
2. Verified that **August 2026 is explicitly marked PARTIAL** (8 days of data: 484 payments = ₹37.24M clean recovery).
3. Standardized Difference-in-Differences terminology: Strategy v3 provided **+₹3,492.80/account net mitigation of yield decay (+₹38.52M volume lift)**.
4. Made test suite 100% portable with relative paths and synchronized test count to 5 tests.
5. Established clean `scripts/` directory for formal reproduction commands.

---

## 3. Final Submission Readiness Status

$$\text{{Final Submission Status: }} \mathbf{{READY}}$$

All factual inconsistencies have been recalculated, reconciled against the Golden Dataset, and synchronized across every repository artifact.
